news.bms.com
Open in
urlscan Pro
2606:4700:7::a29f:810b
Public Scan
Submitted URL: https://d2ctfd04.na1.hubspotlinks.com/Ctc/OS+113/d2Ctfd04/VVJfC07MZmZXW5Bm8TG5Lqtp3W1zSvF_4X17zcN95jt9m5nKwVV3Zsc37CgBJgW2DppbP1_38G0W...
Effective URL: https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Launches-Disability-Diversity-in-Clinical-Trials-DDiCT-In...
Submission: On February 14 via api from US — Scanned from DE
Effective URL: https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Launches-Disability-Diversity-in-Clinical-Trials-DDiCT-In...
Submission: On February 14 via api from US — Scanned from DE
Form analysis 1 forms found in the DOM
POST default.aspx?utm_campaign=DDiCT+PWD+Survey&utm_medium=email&_hsmi=246052778&_hsenc=p2ANqtz-9po2ZwaJcA24zrLamD83oVn7TJZKbLKwiotrbWr43BwERordB7YrGMIkXkp8Oz5m2cGzCg32J6t9fm6ad71ZemL6n_zA&utm_content=246052778&utm_source=hs_automation
<form
action="default.aspx?utm_campaign=DDiCT+PWD+Survey&utm_medium=email&_hsmi=246052778&_hsenc=p2ANqtz-9po2ZwaJcA24zrLamD83oVn7TJZKbLKwiotrbWr43BwERordB7YrGMIkXkp8Oz5m2cGzCg32J6t9fm6ad71ZemL6n_zA&utm_content=246052778&utm_source=hs_automation"
method="post" id="fmForm1">
<div class="aspNetHidden">
<input type="hidden" name="__EVENTTARGET" id="__EVENTTARGET" value="">
<input type="hidden" name="__EVENTARGUMENT" id="__EVENTARGUMENT" value="">
<input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="">
</div>
<script type="text/javascript">
//<![CDATA[
var theForm = document.forms['fmForm1'];
if (!theForm) {
theForm = document.fmForm1;
}
function __doPostBack(eventTarget, eventArgument) {
if (!theForm.onsubmit || (theForm.onsubmit() != false)) {
theForm.__EVENTTARGET.value = eventTarget;
theForm.__EVENTARGUMENT.value = eventArgument;
theForm.submit();
}
}
//]]>
</script>
<script type="text/javascript">
//<![CDATA[
function GetViewType() {
return '2';
}
function GetRevisionNumber() {
return '1';
}
function GetLanguageId() {
return '1';
}
function GetVersionNumber() {
return '5.88.1.2';
}
function GetPoweredBy() {
return 'q4inc';
}
function GetViewDate() {
{
return '';
}
}
function GetSignature() {
{
return '';
}
}
//]]>
</script>
<div class="layout layout--two-column">
<div class="layout_inner">
<div class="layout_header">
<div class="pane pane--header">
<div class="pane_inner"><span class="HeaderPaneDiv"><span class="HeaderPaneDiv1">
<div id="_ctrl0_ctl06_divModuleContainer" class="module module-embed module-logo">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<a href="https://www.bms.com/"><img src="//s25.q4cdn.com/566753351/files/design/bms-rebrand-logo.svg" alt="BMS logo"></a>
</div>
</div>
</div>
</span></span></div>
</div>
<div class="pane pane--banner">
<div class="pane_inner"></div>
</div>
<div class="pane pane--navigation">
<div class="pane_inner"></div>
</div>
</div>
<div class="layout_content" id="maincontent">
<div class="pane pane--breadcrumb">
<div class="pane_inner"></div>
</div>
<div class="pane pane--left">
<div class="pane_inner"><span class="LeftPaneDiv"></span></div>
</div>
<div class="pane pane--content">
<div class="pane_inner"><span class="ContentPaneDiv"><span class="ContentPaneDiv2">
<div id="_ctrl0_ctl09_divModuleContainer" class="module module-embed module-email-rss">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<div class="module-see">
<a href="/news/default.aspx" class="button--cta" target="_blank">See All Press Releases</a>
</div>
<div class="module-alerts">
<a href="/subscribe/default.aspx" class="button--cta" target="_blank">Sign up for Email Alerts</a>
</div>
<div class="module-press">
<a href="https://www.bms.com/media/press-releases/press-release-rss-feeds.html" class="button--cta" target="_blank">Press Release RSS</a>
</div>
</div>
</div>
</div>
</span><span class="ContentPaneDiv1">
<div id="_ctrl0_ctl30_divModuleContainer" class="module module-details module-news-details" data-tag="">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<h3 class="module-details_title">
<span id="_ctrl0_ctl30_lblModuleDetailHeadline">Bristol Myers Squibb Launches Disability Diversity in Clinical Trials (DDiCT) Initiative to Improve Healthcare Outcomes for People with Disabilities</span>
</h3>
<div class="module_container module_container--content">
<div class="module_date-time">
<span id="_ctrl0_ctl30_lblDate" class="module_date-text">07/20/2022</span>
</div>
<div class="module_category">
<div class="module_category-container"><span>Category:</span>
<ul>
<li><a href="/news/news-releases-category/default.aspx?cat="></a></li>
</ul>
</div>
</div>
<div class="module_links q4icons">
<div class="module_related-document">
<a id="_ctrl0_ctl30_hrefDownload" class="module_link module_news-details_download" target="_blank" style="DISPLAY:none;">
<span class="q4icons_icon" aria-hidden="true"></span>
<span id="_ctrl0_ctl30_lblDownload" class="module_link-text">Download</span>
<span class="sr-only">PDF Format (opens in new window)</span>
<span id="_ctrl0_ctl30_lblDocument" class="module_file-size"></span>
</a>
</div>
</div>
<div class="module_body">
<style type="text/css">
.q4default .bwalignc {
text-align: center;
list-style-position: inside
}
</style>
<div class="q4default">
<p><span class="bw-dateline-wrapper">PRINCETON, N.J.--(BUSINESS WIRE)--</span>
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.bms.com%2Fabout-us.html&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Bristol+Myers+Squibb&index=1&md5=f46653b5bc241ccd52430b4b0b220c0f" rel="nofollow" shape="rect">Bristol Myers Squibb</a>
(NYSE:BMY) today announced, in collaboration with
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.disabilitytalent.org%2F&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Disability+Solutions%2C&index=2&md5=7a16de1d6c63adc0ae56a9668a3ca5f3" rel="nofollow" shape="rect">Disability Solutions,</a>
a U.S.- based non-profit organization that supports companies globally to achieve true disability inclusion, the launch of the Disability Diversity in Clinical Trials (DDiCT) initiative. This new initiative aligns with
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.bms.com%2Fabout-us%2Fglobal-diversity-and-inclusion%2Four-commitments.html&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Bristol+Myers+Squibb%26%238217%3Bs+broader+inclusion+and+diversity+health+equity+commitments&index=3&md5=65ebeb204f56cb5f3b80626e6f1bafc3" rel="nofollow" shape="rect">Bristol Myers Squibb’s broader inclusion and diversity health equity commitments</a>
to address health disparities, clinical trial diversity, supplier diversity, employee giving, and workforce representation between 2020 and 2025.
</p>
<p> The DDiCT initiative initially aims to make recommendations on how to effectively improve access, engagement, speed of enrollment, and participation of people with disabilities in clinical trials, to ensure all patient
groups are reflective of the real-world population and aligned with the epidemiology of the disease studies. This project was initiated by the Bristol Myers Squibb
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.bms.com%2Fabout-us%2Fglobal-diversity-and-inclusion%2Fpeople-and-business-resource-groups.html&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=People+%26amp%3B+Business+Resource+Group+DAWN&index=4&md5=0a66156c91f67967bffd4a2e36e7d522" rel="nofollow" shape="rect">People & Business Resource Group DAWN</a>
(Disability Advancement Workplace Network) and will be co-led by DAWN and the Global Drug Development Team. </p>
<p> "Through this work, Bristol Myers Squibb can set the standard and stage for access to life-changing and life-saving medicines for people with disabilities,” said Samit Hirawat, M.D., executive vice president and chief
medical officer, Global Drug Development, Bristol Myers Squibb. “The long-term goal of our DDiCT program is to develop and pilot trials that are accessible to the widest variety of patients.” </p>
<p> Current common clinical trial practices exclude up to one-fourth of the U.S. population-based on disability status. According to a study published in the
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjama%2Farticle-abstract%2F2667821%3Fredirect%3Dtrue%26appId%3Dscweb&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Journal+of+the+American+Medical+Association%2C&index=5&md5=24fab5c7922ad23c0b55d84895ec44c6" rel="nofollow" shape="rect">Journal of the American Medical Association,</a>
in 338 phase III and IV studies, 12.4% of people with intellectual or developmental disabilities and 1.8% of those with physical disabilities failed to be included due to explicit exclusion criteria. The study also
identified that additional barriers for disability diversity within clinical trials are caused by inaccessible trial sites, medical equipment, and ableist biases which deter this community from receiving potentially
life-saving treatments. </p>
<p> “People with disabilities are omitted from conversations about diversity and inclusion, despite being the largest underrepresented group in the world and the only underrepresented group anyone can join at any given
moment. Therefore, it’s essential that we broaden the scope of medical trials and research,” said Tinamarie Duff, DAWN Global People & Business Resource Group Lead, Bristol Myers Squibb. “The launch of the DDiCT,
especially during Disability Pride Month, supports Bristol Myers Squibb’s overall commitment to address every dimension of diversity, which means making the most effective medicine to include people with disabilities at
all stages of access/trials.” </p>
<p>
<b>About Bristol Myers Squibb</b>
</p>
<p> Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol
Myers Squibb, visit us at
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.bms.com%2F&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=BMS.com&index=6&md5=4aa2ca4876dd3549bba309d7c4325d24" rel="nofollow" shape="rect">BMS.com</a>
or follow us
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F1773%3Ftrk%3Dtyah%26trkInfo%3DclickedVertical%253Acompany%252CclickedEntityId%253A1773%252Cidx%253A2-1-2%252CtarId%253A1462816198861%252Ctas%253Abristol-&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=LinkedIn&index=7&md5=1a2921b29e430cb4728a7100355d62c6" rel="nofollow" shape="rect">LinkedIn</a>,
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftwitter.com%2Fbmsnews&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Twitter&index=8&md5=97d2d04b84e98f694338783fab52289c" rel="nofollow" shape="rect">Twitter</a>,
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCjFf4oKibYrHae2NZ_GPS6g&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=YouTube&index=9&md5=e1a1dd23563f18e1058d8e83e03e486a" rel="nofollow" shape="rect">YouTube</a>,
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2Fbristolmyerssquibb&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Facebook&index=10&md5=335e4efa17a2702a0d7425bbcbd4994c" rel="nofollow" shape="rect">Facebook</a>,
and
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fbristolmyerssquibb%2F&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=Instagram&index=11&md5=b361d37d8d2898a487df388ab179f2ea" rel="nofollow" shape="rect">Instagram</a>.
</p>
<p>
<b>About Disability Solutions</b>
</p>
<p> Disability Solutions is a division of Ability Beyond and works directly with forward thinking and inclusive companies who have identified the value of being inclusive of people with disabilities in all facets of their
organization. Disability Solutions works with more than 60 companies globally to drive true disability inclusion. Their motto is “Changing Minds and Changing Lives”. Disability Solutions understands that when corporate
leaders engage with the value and humanity the disability community brings forward, they will be able to drive life-changing – and in this case – life-saving change which will echo across the world. You can learn more
about Disability Solutions at
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.disabilitytalent.org&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=www.disabilitytalent.org&index=12&md5=27b58b31c1f977fc217507f18416fb9e" rel="nofollow" shape="rect">www.disabilitytalent.org</a>.
</p>
<p> About Disability Solutions Parent Company: Ability Beyond, Inc. is a nonprofit 501(c)3 organization whose mission is to provide health and human services to adults with disabilities throughout Connecticut and
Westchester County, NY. Founded more than 60 years ago, Ability Beyond has its headquarters in Bethel, CT, and Chappaqua, NY. Ability Beyond employs 1,200 people and has an annual budget of $71,000,000. Jane Davis,
President/CEO, and her Executive Team manage the agency, with oversight from the Ability Beyond Board of Directors. Major revenue sources include Medicaid, Medicare, government contracts, fees for service, and
philanthropic support. You can learn more about Ability Beyond at
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fabilitybeyond.org%2F&esheet=52785780&newsitemid=20220720005158&lan=en-US&anchor=www.abilitybeyond.org&index=13&md5=1eab52d4969cc3eedb5099ed1a983958" rel="nofollow" shape="rect">www.abilitybeyond.org</a>.
</p>
<p> For press inquiries related to Disability Solutions or Ability Beyond, please contact Julie Sowash, Executive Director of Disability Solutions at
<a href="mailto:julie.sowash@disabilitytalent.org" rel="nofollow" shape="rect">Julie.Sowash@DisabilityTalent.org</a>. </p>
<p> PARTNERING NEWS </p>
<p>
<img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20220720005158r1&sid=q4-prod&distro=nx&lang=en" style="width:0;height:0">
<span class="bwct31415"></span>
</p>
<div class="bw-contact-info-wrapper">
<p>
<b>Media Inquiries:
</b>
<br>
<a href="mailto:media@bms.com" rel="nofollow" shape="rect">media@bms.com</a>
</p>
</div> <span class="bw-source-text-wrapper">Source: Bristol Myers Squibb</span>
</div>
</div>
<p class="module_multimedia-title"><strong>Multimedia Files:</strong></p>
<div id="_ctrl0_ctl30_ulMultimedia" class="module_multimedia grid">
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_mediaItem" class="module_multimedia-item grid_col grid_col--1-of-4 grid_col--lg-1-of-4 grid_col--lc-1-of-3 grid_col--md-1-of-2">
<a href="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO.jpg" id="_ctrl0_ctl30_rptMultimedia_ctl00_hrefFile" target="_blank" data-fancybox="" class="module_link">
<img src="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO@thumbnail.png" id="_ctrl0_ctl30_rptMultimedia_ctl00_imgMedia" class="module_multimedia-image">
</a>
<div class="module_multimedia-caption">
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_lblMediaFileText" class="module_file-text">BMS_LOGO.jpg</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_lblFileResolution" class="module_file-resolution">1502 x 208</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_lblFileType" class="module_file-type">jpg</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_lblFileSize" class="module_file-size">68 KB</span>
</div>
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_ulMultimediaSizes" class="module_multimedia-sizes">
<span class="module_link-text">Download:</span>
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_mediaItemSize" class="module_multimedia-size">
<a href="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO.jpg" id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_hrefSize" target="_blank" class="module_link" download="">
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_lblMediaFileSizeText" class="module_link-text">Download original</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_lblMediaFileSizeType" class="module_file-type">jpg</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_lblMediaFileSizeSize" class="module_file-size">68 KB</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl00_lblMediaFileSizeResolution" class="module_file-resolution">1502 x 208</span>
</a>
</div>
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_mediaItemSize" class="module_multimedia-size">
<a href="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO@thumbnail.png" id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_hrefSize" target="_blank" class="module_link" download="">
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_lblMediaFileSizeText" class="module_link-text">Download thumbnail</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_lblMediaFileSizeType" class="module_file-type">png</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_lblMediaFileSizeSize" class="module_file-size">5 KB</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl01_lblMediaFileSizeResolution" class="module_file-resolution">200 x 28</span>
</a>
</div>
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_mediaItemSize" class="module_multimedia-size">
<a href="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO@lowres.png" id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_hrefSize" target="_blank" class="module_link" download="">
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_lblMediaFileSizeText" class="module_link-text">Download lowres</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_lblMediaFileSizeType" class="module_file-type">png</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_lblMediaFileSizeSize" class="module_file-size">17 KB</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl02_lblMediaFileSizeResolution" class="module_file-resolution">480 x 66</span>
</a>
</div>
<div id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_mediaItemSize" class="module_multimedia-size">
<a href="//s25.q4cdn.com/566753351/files/doc_multimedia/BMS_LOGO@square.png" id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_hrefSize" target="_blank" class="module_link" download="">
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_lblMediaFileSizeText" class="module_link-text">Download square</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_lblMediaFileSizeType" class="module_file-type">png</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_lblMediaFileSizeSize" class="module_file-size">8 KB</span>
<span id="_ctrl0_ctl30_rptMultimedia_ctl00_rptMultimediaSizes_ctl03_lblMediaFileSizeResolution" class="module_file-resolution">250 x 250</span>
</a>
</div>
</div>
</div>
</div>
<div class="module-news-details_category">
<span id="_ctrl0_ctl30_lblCategory" class="module-news-details_category-text">Categories:</span>
<span id="_ctrl0_ctl30_rptCategories_ctl00_lblCategoryName" class="module-news-details_category-name">Press Releases</span>
</div>
</div>
</div>
</div>
</div>
</span></span></div>
</div>
<div class="pane pane--right">
<div class="pane_inner"><span class="RightPaneDiv"><span class="RightPaneDiv7">
<div id="_ctrl0_ctl24_divModuleContainer" class="module module-embed module-add-to-any">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<!-- AddToAny BEGIN -->
<div class="a2a_kit a2a_kit_size_32 a2a_default_style" style="line-height: 32px;">
<a class="a2a_button_twitter q4-icon_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="a2a_svg a2a_s__default a2a_s_twitter" style="background-color: rgb(29, 155, 240);"><svg focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><path fill="#FFF" d="M28 8.557a9.913 9.913 0 0 1-2.828.775 4.93 4.93 0 0 0 2.166-2.725 9.738 9.738 0 0 1-3.13 1.194 4.92 4.92 0 0 0-3.593-1.55 4.924 4.924 0 0 0-4.794 6.049c-4.09-.21-7.72-2.17-10.15-5.15a4.942 4.942 0 0 0-.665 2.477c0 1.71.87 3.214 2.19 4.1a4.968 4.968 0 0 1-2.23-.616v.06c0 2.39 1.7 4.38 3.952 4.83-.414.115-.85.174-1.297.174-.318 0-.626-.03-.928-.086a4.935 4.935 0 0 0 4.6 3.42 9.893 9.893 0 0 1-6.114 2.107c-.398 0-.79-.023-1.175-.068a13.953 13.953 0 0 0 7.55 2.213c9.056 0 14.01-7.507 14.01-14.013 0-.213-.005-.426-.015-.637.96-.695 1.795-1.56 2.455-2.55z"></path></svg></span><span class="a2a_label">Twitter</span></a>
<a class="a2a_button_linkedin q4-icon_linkedin-square" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="a2a_svg a2a_s__default a2a_s_linkedin" style="background-color: rgb(0, 123, 181);"><svg focusable="false" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><path d="M6.227 12.61h4.19v13.48h-4.19V12.61zm2.095-6.7a2.43 2.43 0 0 1 0 4.86c-1.344 0-2.428-1.09-2.428-2.43s1.084-2.43 2.428-2.43m4.72 6.7h4.02v1.84h.058c.56-1.058 1.927-2.176 3.965-2.176 4.238 0 5.02 2.792 5.02 6.42v7.395h-4.183v-6.56c0-1.564-.03-3.574-2.178-3.574-2.18 0-2.514 1.7-2.514 3.46v6.668h-4.187V12.61z" fill="#FFF"></path></svg></span><span class="a2a_label">LinkedIn</span></a>
<div style="clear: both;"></div>
</div>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>
<!-- AddToAny END -->
</div>
</div>
</div>
</span></span></div>
</div>
</div>
<div class="layout_footer" role="contentinfo">
<div class="pane pane--footer">
<div class="pane_inner"><span class="FooterPaneDiv"></span></div>
</div>
<div class="pane pane--footer2">
<div class="pane_inner"></div>
</div>
<div class="pane pane--credits">
<div class="pane_inner"><span class="Q4FooterDiv3">
<div id="_ctrl0_ctl12_divModuleContainer" class="module module-embed module-policy">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<a href="https://www.bms.com/privacy-policy.html">Privacy Policy</a>
</div>
</div>
</div>
</span><span class="Q4FooterDiv4">
<div id="_ctrl0_ctl15_divModuleContainer" class="module module-embed hidden">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<script>
var pymChild = new pym.Child();
var q4App = $.extend(true, q4Defaults, {
fancySignup: function() {
var inst = this,
validationLock = true,
signup = inst.options.mailingListSignupCls,
$signup = $(signup),
confirm = 'div[id*="SubscriberConfirmation"]',
$confirm = $('div[id*="SubscriberConfirmation"]'), // jshint ignore:line
footerSuccess = inst.options.mailingListConfig.location + ' ' + confirm + ' .module_message--success',
$footerSuccess = $(footerSuccess);
// Subscriber Confirmation fix
if ($confirm.is(':visible')) {
if ($confirm.filter(':visible').closest(inst.options.mailingListConfig.location).length) {
var successText = $confirm.filter(':visible').closest(inst.options.mailingListConfig.location).find('.module_message--success').text();
$confirm.filter(':visible').parent().html(inst.options.mailingListConfig.tpl).find('.module_message--success').html(successText);
}
inst.scrollTo($('div[id*="SubscriberConfirmation"]').filter(':visible'), 0);
if (!$footerSuccess.length) {
$('.module-unsubscribe,' + inst.options.mailingListConfig.hideOnConfirmation).addClass('js--hidden');
}
}
if (!$signup.length) {
return;
}
$signup.each(function() {
var $this = $(this);
// If a confirmation or error message is visible on page load, scroll to the module
if ($this.find('input.module_input').length && $this.find('input.module_input').val().length) {
inst.scrollTo($this, 0);
}
// Create a second submit button to be displayed inside fancybox. Replace input type submit with button
var $submit = $this.find('input[type="submit"]');
$submit.addClass('js--hidden');
$submit[0].outerHTML = $submit[0].outerHTML.replace(/^<input/, '<button') + '<span class="button_text">' + $submit[0].value + '</span></button>';
$this.find('.module_actions').append('<button type="submit" class="button module-subscribe_submit-button module-subscribe_submit-button--fancy"><span class="button_text">' + inst.options.mailingListConfig
.submitText + '</span></button>');
$this.on('click', '.module-subscribe_submit-button--fancy', function(e) {
e.preventDefault();
validationLock = false;
var $parent = $(this).closest(signup),
errors = inst._mailingListValidation($parent);
if (!errors.length) {
$(this).closest(signup).find('.module_actions [type="submit"]').not(this).trigger('click');
return false;
} else {
inst.scrollTo($this.find('.module_error-container'), 0);
}
return false;
});
// Run validation on change
$this.find('input, select').on('change', function() {
if (!validationLock) {
inst._mailingListValidation($this);
}
});
// Validate submit on enter
$this.find('input[type="text"], input[type="email"]').on('keydown', function(e) {
if (e.keyCode == 13) {
e.preventDefault();
$(this).closest(signup).find('.module_actions [type="submit"]').trigger('click');
return false;
}
});
});
},
scrollingTable: function(selector) {
$(selector).not(selector + ' table').wrap('<div class="table-wrapper" />');
},
iconFix: function() {
$('.q4icons .module_link').each(function() {
if (!$(this).children('.q4icons_icon').length) {
$(this).prepend('<span class="q4icons_icon" aria-hidden="true"></span>');
}
});
},
init: function() {
var app = this;
app.cleanUp();
app.submitOnEnter('.module-unsubscribe');
app.docTracking();
app.fancySignup();
app.resetDate(['.nav a[href*="s4.q4web.com"]:not([href$=".pdf"])']);
app.previewToolbar();
app.iconFix();
if ($('.module-unsubscribe').length) app.validateUnsubscribe($('.module-unsubscribe'));
$('.module').on('click', '*', function() {
pymChild.sendHeight();
}).on('change', 'input, select', function() {
pymChild.sendHeight();
});
if ($('.module_message--success').length) {
pymChild.sendHeight();
}
}
});
q4App.init();
</script>
</div>
</div>
</div>
</span><span class="Q4FooterDiv5">
<div id="_ctrl0_ctl18_divModuleContainer" class="module module-embed">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<script type="text/javascript" src="https://www.bugherd.com/sidebarv2.js?apikey=qnecbnsxpp7ptpsenhgvdw" async="true"></script>
</div>
</div>
</div>
</span><span class="Q4FooterDiv6">
<div id="_ctrl0_ctl21_divModuleContainer" class="module module-embed hidden">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<script type="text/javascript">
var contactInfo = $('.bw-news-contactinfo').text();
var newContactInfo = contactInfo.split(' ').join('<br>').split(' ').join('<br>');
$('.bw-news-contactinfo').html(newContactInfo);
$('.bw-news-contactinfo').prepend('<p><strong>Contact:</strong></p>');
</script>
</div>
</div>
</div>
</span><span class="Q4FooterDiv8">
<div id="_ctrl0_ctl27_divModuleContainer" class="module module-embed hidden">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<script type="text/javascript">
_satellite.pageBottom();
</script>
<script>
function onPlayerStateChange(event) {
//var s = _satellite.getToolsByType('sc')[0].getS();
var videoPlayer = 'youtube';
var mediaName = event.target.getVideoData().title.toLowerCase();
var mediaLength = Math.floor(event.target.getDuration());
var mediaOffset = Math.floor(event.target.getCurrentTime());
if (event.data == YT.PlayerState.PLAYING) {
if (mediaOffset == 0) {
s.Media.open(mediaName, mediaLength, videoPlayer);
}
s.Media.play(mediaName, mediaOffset);
}
if (event.data == YT.PlayerState.PAUSED) {
s.Media.stop(mediaName, mediaOffset);
}
if (event.data == YT.PlayerState.BUFFERING) {
s.Media.stop(mediaName, mediaOffset);
}
if (event.data == YT.PlayerState.ENDED) {
s.Media.stop(mediaName, mediaOffset);
s.Media.close(mediaName);
mediaOffset = 0;
}
}
</script>
<script>
function onHTML5VideoEvents(e) {
// var s = _satellite.getToolsByType('sc')[0].getS();
var vidObj = $(e.currentTarget);
var mediaName = vidObj[0].currentSrc.trim().toLowerCase().split('/').pop();
var mediaLength = Math.floor(vidObj[0].duration);
var mediaPlayer = 'html5 video player';
var mediaOffset = vidObj[0].currentTime > 0 ? Math.floor(vidObj[0].currentTime) : 0;
var dataVideo = vidObj[0].dataset.videoId;
if (dataVideo) {
if (dataVideo === '6113798686001') {
mediaName = 'Samit Hirawat on 2019 ASH meeting';
}
if (dataVideo === '6109725083001') {
mediaName = 'CAR T Cell Therapy';
}
}
switch (e.type) {
case 'playing':
if (mediaOffset == 0) {
s.Media.open(mediaName, mediaLength, mediaPlayer);
}
s.Media.play(mediaName, mediaOffset);
break;
case 'seeked':
s.Media.play(mediaName, mediaOffset);
break;
case 'seeking':
s.Media.stop(mediaName, mediaOffset);
break;
case 'pause':
s.Media.stop(mediaName, mediaOffset);
break;
case 'ended':
s.Media.stop(mediaName, mediaOffset);
s.Media.close(mediaName);
mediaOffset = 0;
break;
}
}
</script>
<script>
/*!
* jQuery initialize - v1.0.0 - 12/14/2016
* https://github.com/adampietrasiak/jquery.initialize
*
* Copyright (c) 2015-2016 Adam Pietrasiak
* Released under the MIT license
* https://github.com/timpler/jquery.initialize/blob/master/LICENSE
*/
! function(i) {
"use strict";
var t = function(i, t) {
this.selector = i, this.callback = t
},
e = [];
e.initialize = function(e, n) {
var c = [],
a = function() {
-1 == c.indexOf(this) && (c.push(this), i(this).each(n))
};
i(e).each(a), this.push(new t(e, a))
};
var n = new MutationObserver(function() {
for (var t = 0; t < e.length; t++) i(e[t].selector).each(e[t].callback)
});
n.observe(document.documentElement, {
childList: !0,
subtree: !0,
attributes: !0
}), i.fn.initialize = function(i) {
e.initialize(this.selector, i)
}, i.initialize = function(i, t) {
e.initialize(i, t)
}
}(jQuery);
</script>
</div>
</div>
</div>
</span><span class="Q4FooterDiv2">
<div id="_ctrl0_ctl33_divModuleContainer" class="module module-embed">
<div class="module_container module_container--outer">
<div class="module_container module_container--inner">
<script type="text/javascript">
q4App.scrollingTable('.module-details .module_body table');
var tagsObj = {
'Corporate-Financial-News': 'Corporate/Financial News',
'Philanthropy-News': 'Philanthropy News',
'R-D-News': 'R&D News',
'Partnering-News': 'Partnering News',
},
tags = $('.module-news-details').data('tag').split(','),
template = '<div class="module_category-container"><span>Category:</span> <ul>{{#.}}<li><a href="/news/news-releases-category/default.aspx?cat={{tag}}">{{name}}</a></li>{{/.}}</div>',
tagItems = [];
$.each(tags, function(i, tag) {
tagItems.push({
'name': tagsObj[tag] != undefined ? tagsObj[tag] : tag,
'tag': tag
});
});
$('.module-news-details .module_category').prepend(Mustache.render(template, tagItems));
if (!$('.module-news-details .module_multimedia').length > 0) {
$('.module-news-details .module_multimedia-title').remove();
}
// shift spaces to correct press release formatting issues
$(document).ready(function() {
shiftSpaces($('.module-news-details .module_container--inner'));
});
function shiftSpaces($elem) {
var recurse = false;
// find all text nodes
$('*', $elem).addBack().contents().filter(function() {
if (this.nodeType === 3) return true;
}).each(function() {
// shift leading spaces
if ($(this).prev().length === 0 && this.data.charAt(0) === ' ') {
$(this).parent().before(document.createTextNode(' '));
this.data = this.data.substring(1);
recurse = true;
}
// shift trailing spaces
if ($(this).next().length === 0 && this.data.charAt(this.data.length - 1) === ' ') {
$(this).parent().after(document.createTextNode(' '));
this.data = this.data.substring(0, this.data.length - 1);
recurse = true;
}
});
// merge adjacent text nodes
$elem[0].normalize();
// if any spaces were shifted, recurse
if (recurse) shiftSpaces($elem);
}
</script>
<script async="" src="https://static.addtoany.com/menu/page.js"></script>
</div>
</div>
</div>
</span></div>
</div>
</div>
</div>
</div>
<input type="hidden" name="__antiCSRF" id="__antiCSRF" value="">
</form>Text Content
See All Press Releases Sign up for Email Alerts Press Release RSS BRISTOL MYERS SQUIBB LAUNCHES DISABILITY DIVERSITY IN CLINICAL TRIALS (DDICT) INITIATIVE TO IMPROVE HEALTHCARE OUTCOMES FOR PEOPLE WITH DISABILITIES 07/20/2022 Category: * Download PDF Format (opens in new window) PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today announced, in collaboration with Disability Solutions, a U.S.- based non-profit organization that supports companies globally to achieve true disability inclusion, the launch of the Disability Diversity in Clinical Trials (DDiCT) initiative. This new initiative aligns with Bristol Myers Squibb’s broader inclusion and diversity health equity commitments to address health disparities, clinical trial diversity, supplier diversity, employee giving, and workforce representation between 2020 and 2025. The DDiCT initiative initially aims to make recommendations on how to effectively improve access, engagement, speed of enrollment, and participation of people with disabilities in clinical trials, to ensure all patient groups are reflective of the real-world population and aligned with the epidemiology of the disease studies. This project was initiated by the Bristol Myers Squibb People & Business Resource Group DAWN (Disability Advancement Workplace Network) and will be co-led by DAWN and the Global Drug Development Team. "Through this work, Bristol Myers Squibb can set the standard and stage for access to life-changing and life-saving medicines for people with disabilities,” said Samit Hirawat, M.D., executive vice president and chief medical officer, Global Drug Development, Bristol Myers Squibb. “The long-term goal of our DDiCT program is to develop and pilot trials that are accessible to the widest variety of patients.” Current common clinical trial practices exclude up to one-fourth of the U.S. population-based on disability status. According to a study published in the Journal of the American Medical Association, in 338 phase III and IV studies, 12.4% of people with intellectual or developmental disabilities and 1.8% of those with physical disabilities failed to be included due to explicit exclusion criteria. The study also identified that additional barriers for disability diversity within clinical trials are caused by inaccessible trial sites, medical equipment, and ableist biases which deter this community from receiving potentially life-saving treatments. “People with disabilities are omitted from conversations about diversity and inclusion, despite being the largest underrepresented group in the world and the only underrepresented group anyone can join at any given moment. Therefore, it’s essential that we broaden the scope of medical trials and research,” said Tinamarie Duff, DAWN Global People & Business Resource Group Lead, Bristol Myers Squibb. “The launch of the DDiCT, especially during Disability Pride Month, supports Bristol Myers Squibb’s overall commitment to address every dimension of diversity, which means making the most effective medicine to include people with disabilities at all stages of access/trials.” About Bristol Myers Squibb Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us LinkedIn, Twitter, YouTube, Facebook, and Instagram. About Disability Solutions Disability Solutions is a division of Ability Beyond and works directly with forward thinking and inclusive companies who have identified the value of being inclusive of people with disabilities in all facets of their organization. Disability Solutions works with more than 60 companies globally to drive true disability inclusion. Their motto is “Changing Minds and Changing Lives”. Disability Solutions understands that when corporate leaders engage with the value and humanity the disability community brings forward, they will be able to drive life-changing – and in this case – life-saving change which will echo across the world. You can learn more about Disability Solutions at www.disabilitytalent.org. About Disability Solutions Parent Company: Ability Beyond, Inc. is a nonprofit 501(c)3 organization whose mission is to provide health and human services to adults with disabilities throughout Connecticut and Westchester County, NY. Founded more than 60 years ago, Ability Beyond has its headquarters in Bethel, CT, and Chappaqua, NY. Ability Beyond employs 1,200 people and has an annual budget of $71,000,000. Jane Davis, President/CEO, and her Executive Team manage the agency, with oversight from the Ability Beyond Board of Directors. Major revenue sources include Medicaid, Medicare, government contracts, fees for service, and philanthropic support. You can learn more about Ability Beyond at www.abilitybeyond.org. For press inquiries related to Disability Solutions or Ability Beyond, please contact Julie Sowash, Executive Director of Disability Solutions at Julie.Sowash@DisabilityTalent.org. PARTNERING NEWS Media Inquiries: media@bms.com Source: Bristol Myers Squibb Multimedia Files: BMS_LOGO.jpg 1502 x 208 jpg 68 KB Download: Download original jpg 68 KB 1502 x 208 Download thumbnail png 5 KB 200 x 28 Download lowres png 17 KB 480 x 66 Download square png 8 KB 250 x 250 Categories: Press Releases Twitter LinkedIn Privacy Policy ✓ Thanks for sharing! AddToAny More…